Dilazep
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | C01DX10 (WHO) |
| Identifiers | |
| |
| PubChem (CID) | 3074 |
| IUPHAR/BPS | 4717 |
| ChemSpider |
2965 |
| UNII |
F8KLC2BD5Z |
| KEGG |
D07843 |
| ChEMBL |
CHEMBL126075 |
| Chemical and physical data | |
| Formula | C31H44N2O10 |
| Molar mass | 604.69 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
Dilazep is a vasodilator that acts as an adenosine reuptake inhibitor.[1]
See also
- Hexobendine, a drug with similar chemical structure
References
- ↑ Hiroshi Deguchi; Hiroyuki Takeya; Hideo Wada; Esteban C. Gabazza; Nobuyuki Hayashi; Hajime Urano; Koji Suzuki (September 15, 1997). "Dilazep, an Antiplatelet Agent, Inhibits Tissue Factor Expression in Endothelial Cells and Monocytes". Blood. 90: 2345–2356.
This article is issued from Wikipedia - version of the 5/29/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
